Association between high-sensitivity C-reactive protein and N-Terminal Pro-B-Type Natriuretic Peptide in patients

Wenliang Che1, Buchun Zhang, Wenling Liu

  • 1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China. chewenliang@tongji.edu.cn

Insights

Hepatitis C virus (HCV) patients showed lower high-sensitivity C-reactive protein (hs-CRP) levels but a significant correlation between hs-CRP and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP). This suggests a link between inflammation and cardiac function in HCV infection.

Area of Science:

  • Cardiology
  • Hepatology
  • Inflammation Research

Background:

  • Previous research indicates elevated N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and potential left ventricular diastolic dysfunction in Hepatitis C Virus (HCV) infected patients.
  • Investigating high-sensitivity C-reactive protein (hs-CRP) characteristics and its clinical correlations in HCV patients is crucial.

Purpose of the Study:

  • To examine the characteristics of hs-CRP in HCV-infected patients.
  • To determine the correlation between hs-CRP and clinical profiles, including NT-proBNP and echocardiographic variables.

Main Methods:

  • A study involving 106 HCV-infected patients and 106 healthy controls.
  • Serum hs-CRP and NT-proBNP levels were measured.
  • Regression analysis was used to identify independent correlates of hs-CRP.

Main Results:

  • Serum hs-CRP levels were significantly lower in HCV patients compared to controls (P = 0.012).
  • A significant linear correlation was found between hs-CRP and NT-proBNP in HCV patients (r = 0.392, P = 0.017).
  • Independent correlates of hs-CRP included older age and higher NT-proBNP levels.

Conclusions:

  • Despite significantly decreased hs-CRP levels in HCV patients, a significant association exists between hs-CRP and NT-proBNP.
  • These findings highlight a potential link between inflammatory markers and cardiac biomarkers in HCV infection.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...